顺铂
咖啡酸苯乙酯
生长抑制
细胞生长
化学
药理学
细胞毒性
肺癌
癌症研究
癌细胞
药品
化疗
细胞培养
酶抑制剂
抗癌原
体外
生物化学
抗药性
咖啡酸
作用机理
毒性
细胞
肺
抗氧化剂
人肺
后天抵抗
拉顿
生物活性
癌症
酶
作者
Ching-Yi Lee,Yuting Fu,C.‐T. Yeh,LI-KUO KUO,Ying‐Yu Kuo,CHIEH HUO,Shih-Wei Lee,YUNG-CHIA HUANG,LI-JANE SHIH,C Li,Shu‐Pin Huang,Chih‐Jen Lai,Chih‐Pin Chuu
出处
期刊:Anticancer Research
[International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
日期:2025-10-28
卷期号:45 (11): 4971-4986
被引量:1
标识
DOI:10.21873/anticanres.17840
摘要
Background/Aim: Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases. While cisplatin remains standard treatment for NSCLC, development of drug resistance causes failure of treatment. Caffeic acid phenethyl ester (CAPE) has been reported to cause synergistic inhibitory effects with cisplatin in other cancer types. In this study, we investigated whether combination of cisplatin with CAPE enhances the suppression of NSCLC cell proliferation and survival. Materials and Methods: Proliferation assays, MTT assays, and flow cytometry were performed to examine the effects of cisplatin, CAPE and combined treatment on survival and cell cycle of NSCLC cells. Micro-Western Array (MWA) was used to explore the signaling proteins being affected by cisplatin, CAPE or combined treatment. Results: Both agents independently reduced the viability of H1299 and A549 cells in a dose-dependent manner. Combined treatment of cisplatin with CAPE exerted additive suppressive effect compared to cisplatin alone, and the suppressive effects accumulated over time. Flow cytometry analysis revealed that both cisplatin alone and the combination treatment induced G2-M phase cell cycle arrest. Furthermore, MWA analysis showed that the combination treatment repressed the expression of proteins involved in PI3K-AKT signaling and cell cycle progression. Conclusion: Combined treatment of cisplatin with CAPE may reduce the required dose of cisplatin for growth inhibition of NSCLC cells and delay or prevent the development of drug resistance in NSCLC.
科研通智能强力驱动
Strongly Powered by AbleSci AI